US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (193)
  • Diseases & Conditions (3844)
  • Drug Delivery (175)
  • Therapeutic Area (6090)
  • Vaccines (594)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Plague - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Periodontitis - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Brain Injury - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Finland Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... for the treatmentof long-term illnesses, drug manufacturers will be pressured to reduce drug prices as the governmentincreases its cost-containment measures. Political uncertainty along with the country's weak economicoutlook adds further downward pressure to our forecast. ...  |  read more...
USD 1,295
Androgenic Alopecia - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Androgenic Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Pompe Disease - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chronic Urticaria Or Hives - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Chronic Urticaria Or Hives, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Bone Fracture - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Bone Fracture, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... to reduce the proportion ofcounterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers.Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budgetand underdeveloped local manufacturing industry will continue ...  |  read more...
USD 1,295
Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... Pharmaceutical Corp.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Chong Kun Dang Pharmaceutical Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
ELORAC, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of ELORAC, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Ferring International Center S.A. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ferring International Center S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
InterMune, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of InterMune, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Hemorrhagic Fever - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Hemorrhagic Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Allergic Asthma - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Esophageal Cancer - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Esophageal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Post-Operative Pain - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Critical Limb Ischemia - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Critical Limb Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Hyperphosphatemia - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... Hyperphosphatemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325411
12/10/2014 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry, including Average ...  |  read more...
USD 1,995
< prev 1    3  4  5  6  7  8  9  10